Quantum Cyber N.V (QUCY) vs Exagen Inc. (XGN)

Quantum Cyber N.V and Exagen Inc. are both Diagnostics & Research companies. Exagen Inc. is the larger, with a market value of $184.1M against $60.8M — 3.0× the size. Quantum Cyber N.V grew revenue faster over the last twelve months: 69.0% against 20.8%. Quantum Cyber N.V has the higher net margin (0.00% vs −26.6%) and the lower return on invested capital (−194.0% vs −68.3%). Across the 18 metrics below, Quantum Cyber N.V leads on 10 and Exagen Inc. on 8.

Valuation

Metric QUCY XGN Diagnostics & Research median
P/E n/m n/m 34.52
P/S 13.95 2.56 4.24
P/B 0.62 14.88 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA n/m n/m 23.44
EV/Sales 0.78 2.55 5.18
Earnings yield (1,884.74%) (10.77%) (1.50%)
Free cash flow yield (132.86%) (4.17%) 0.00%

Profitability

Metric QUCY XGN Diagnostics & Research median
Gross margin 56.91% 58.64% 48.32%
Operating margin 0.00% (18.58%) (5.68%)
Net margin 0.00% (26.61%) (4.10%)
Free cash flow margin 0.00% (10.66%) 0.00%
Return on equity (325.19%) (113.82%) 0.00%
Return on assets (165.20%) (34.19%) (6.05%)
Return on invested capital (193.99%) (68.33%) 0.00%

Growth

Metric QUCY XGN Diagnostics & Research median
Revenue growth (TTM) 68.99% 20.83% 8.99%
EPS growth (last fiscal year) 87.92% (12.05%) 20.36%
Revenue growth, 5-year CAGR 1.70% 9.66% 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric QUCY XGN Diagnostics & Research median
Debt to equity 0.00 2.00 0.01
Current ratio 5.56 3.18 2.27
Net debt to EBITDA (0.01) 0.68 0.68

Dividend

Metric QUCY XGN Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric QUCY XGN Diagnostics & Research median
Market cap 60.81m 184.11m 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack